Nature Biotechnology, Vol 23:3,  March 05, 2005
Author: Mary-Dell Chilton

Mary-Dell Chilton, of Syngenta, applauds the authors of the Nature paper on their intention "to provide a cost-effective plant transformation technology for ethically desirable projects declined by industry as insufficiently profitable. "

Read the pdf of the article

View PDF (info)